Skip to main content

Dr. Matthew T. Whitehurst, MD

Medical Oncology (Medical Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
11
In the NPI registry since
2009
Medicare patients seen, 2024
1,412

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2015Medical school: University of Maryland School of Medicine
  • 2009Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Medical Oncology Physician primary
    VA license 0101257665
  • Hematology (Internal Medicine) Physician
    VA license 0101257665
  • Internal Medicine Physician
    FL license ME113141
  • Student in an Organized Health Care Education/Training Program

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Medical Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
1,412
Services billed
390,326
Patients’ average age
75
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, ferric carboxymaltose, 1 mg42,75050
Injection, denosumab, 1 mg16,380113
Injection, nivolumab, 1 mg14,82518
Injection, pembrolizumab, 1 mg14,60025
Injection, aprepitant, 1 mg11,83036
Injection, paclitaxel, 1 mg5,92013
Injection, fosaprepitant, 1 mg5,10011
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units3,52041
Injection, epoetin alfa, (for non-esrd use), 1000 units3,46022
Injection, dexamethasone sodium phosphate, 1 mg3,32895

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 30 companies reported 88 payments worth $2,823 in total to this clinician.

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jun 10, 2025Incyte Corporation
Jun 10, 2025
Consulting Fee$860
Oct 2, 2025Janssen Pharmaceuticals, Inc
Oct 2, 2025
Education
in-kind
$20.51

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Virginia →

Industry-funded research

Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $90,051 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Sources

NPI registry (CMS NPPES, November 2026; record last updated December 19, 2019), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1457586208. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.